APT Medical Future Growth
Future criteria checks 6/6
APT Medical is forecast to grow earnings and revenue by 27.4% and 27.2% per annum respectively. EPS is expected to grow by 24.3% per annum. Return on equity is forecast to be 29.1% in 3 years.
Key information
27.4%
Earnings growth rate
24.3%
EPS growth rate
Medical Equipment earnings growth | 24.0% |
Revenue growth rate | 27.2% |
Future return on equity | 29.1% |
Analyst coverage | Good |
Last updated | 29 Apr 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,776 | 1,240 | N/A | 948 | 3 |
12/31/2025 | 2,948 | 947 | N/A | 1,057 | 6 |
12/31/2024 | 2,196 | 703 | N/A | 587 | 5 |
3/31/2024 | 1,756 | 571 | 389 | 687 | N/A |
12/31/2023 | 1,650 | 534 | 487 | 689 | N/A |
9/30/2023 | 1,542 | 501 | 404 | 572 | N/A |
6/30/2023 | 1,448 | 457 | 352 | 519 | N/A |
3/31/2023 | 1,300 | 394 | 267 | 417 | N/A |
12/31/2022 | 1,216 | 358 | 224 | 367 | N/A |
9/30/2022 | 1,123 | 306 | 197 | 371 | N/A |
6/30/2022 | 1,000 | 252 | 103 | 250 | N/A |
3/31/2022 | 933 | 228 | 40 | 206 | N/A |
12/31/2021 | 829 | 208 | 14 | 181 | N/A |
9/30/2021 | 750 | 201 | 39 | 164 | N/A |
6/30/2021 | 671 | 186 | 119 | 223 | N/A |
3/31/2021 | 569 | 149 | 139 | 200 | N/A |
12/31/2020 | 479 | 111 | 104 | 148 | N/A |
9/30/2020 | 442 | 93 | 61 | 110 | N/A |
12/31/2019 | 404 | 83 | -13 | 55 | N/A |
12/31/2018 | 242 | 22 | -14 | 19 | N/A |
12/31/2017 | 153 | 34 | N/A | 13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688617's forecast earnings growth (27.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 688617's earnings (27.4% per year) are forecast to grow faster than the CN market (24.1% per year).
High Growth Earnings: 688617's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688617's revenue (27.2% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 688617's revenue (27.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688617's Return on Equity is forecast to be high in 3 years time (29.1%)